Oppenheimer reiterated coverage on Corbus Pharma with a new price target

6/3/24 7:44:57 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Oppenheimer reiterated coverage of Corbus Pharma with a rating of Outperform and set a new price target of $80.00 from $60.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CRBP

Date	Price Target	Rating	Analyst
2/28/2025		Outperform	William Blair
12/2/2024		Overweight	Piper Sandler
7/30/2024	$85.00	Outperform	Wedbush
7/22/2024	$80.00	Buy	H.C. Wainwright
6/26/2024	$85.00	Buy	B. Riley Securities
6/3/2024	$60.00 → $80.00	Outperform	Oppenheimer
5/13/2024	$77.00	Outperform	RBC Capital Mkts
3/6/2024	$4.00 → $46.00	Hold → Buy	Jefferies